March 17, 2026 · Form 4 insider transaction
Taylor Ben R sold 7,956 shares of Recursion Pharmaceuticals Inc at $3.39 per share, a transaction worth $27.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.